Literature DB >> 30066269

A comparative pathogenicity analysis of two adenovirus strains, 1/A and 8a/E, isolated from poultry in Poland.

Jowita Samanta Niczyporuk1, Hanna Czekaj2.   

Abstract

Fowl adenoviruses (FAdVs) are the causative agents of multietiological syndromes and diseases in poultry flocks. During a routine diagnostic examination, two FAdVs strains were isolated. Molecular typing of these isolates based on the partial loop L1 HVR1-4 region of the hexon gene sequence revealed the presence of different FAdV isolates: 1/A-61/11z (GenBank accession number KX247012, APP94082), and 8a/E-6/12j (GenBank accession number: KP890032, ALB00550), and comparative genome analysis indicated small differences between these two viruses. The next step of the study was the estimation of the pathogenicity of these isolates in specific-pathogen-free (SPF) chickens. Chickens were divided into three groups, with 20 chickens per group infected intraperitoneally on the first day after hatching. Group I consisted of chickens infected with strain FAdV-1/A-61/11z, group II consisted of chickens infected with strain FAdV-8a/E-6/12j, and group III consisted of uninfected birds. Clinical signs observed in infected chickens included poor growth, apathy, prostration, ruffled feathers, crouching position, and huddling behavior. The mortality rate in chickens infected with FAdV-1/A-61/11z was 10% at 10 days postinfection (dpi), and no mortality was observed in chickens infected with the FAdV-8a-6/12j strain. The mean real-time PCR threshold cycle (Ct) value was 39.70%. The detection limit of these assays was 8 copies, with an efficiency of 91.03% and 95.17% and regression square (R2) values of 0.991 and 0.997, respectively, with a mean pathogen load of 4.8 × 106.0 copies/µl. The assays did not demonstrate cross-reactivity between types 1/A and 8a/E and non-targeted poultry viruses. Adenoviral DNA was detected in the liver, spleen, kidney, gizzard, intestine, bursa of Fabricius, and thymus of every examined dead and euthanized chicken from groups I and II between the third and fourth week postinfection. This is the first study conducted on the pathogenic and apathogenic strains FAdV-1/A and FAdV-8a/E, showing the presence of the virus in multiple tissues in chickens in Poland. This study revealed that it is very likely that the FAdV-1/A-61/11z strain is able to cause clinical inclusion body hepatitis (IBH) in chickens and that it is slightly more virulent than the FAdV-8a/E-6/12j strain, although both are primary pathogens of the disease.

Entities:  

Mesh:

Year:  2018        PMID: 30066269     DOI: 10.1007/s00705-018-3965-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Isolation and Characterization of A Novel Fowl Adenovirus Serotype 8a Strain from China.

Authors:  Li Chen; Lijuan Yin; Peng Peng; Qingfeng Zhou; Yunping Du; Yun Zhang; Chunyi Xue; Yongchang Cao
Journal:  Virol Sin       Date:  2019-12-02       Impact factor: 4.327

2.  Characterisation of adenovirus strains represented species B and E isolated from broiler chicken flocks in eastern Poland.

Authors:  Jowita Samanta Niczyporuk; Wojciech Kozdrun; Hanna Czekaj; Karolina Piekarska; Natalia Stys-Fijol
Journal:  Heliyon       Date:  2021-02-17

Review 3.  A recent perspective on fiber and hexon genes proteins analyses of fowl adenovirus toward virus infectivity-A review.

Authors:  Norfitriah Mohamed Sohaimi; Mohd Hair-Bejo
Journal:  Open Vet J       Date:  2021-10-19

4.  Pathogenicity of field strain of fowl aviadenovirus serotype 11 isolated from chickens with inclusion body hepatitis in Morocco.

Authors:  Samira Abghour; Mohamed Mouahid; Sami Darkaoui; Jaouad Berrada; Khalil Zro; Faouzi Kichou
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

5.  Species Fowl aviadenovirus B Consists of a Single Serotype despite Genetic Distance of FAdV-5 Isolates.

Authors:  Győző L Kaján; Anna Schachner; Ákos Gellért; Michael Hess
Journal:  Viruses       Date:  2022-01-27       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.